$4.46
3.48% yesterday
Nasdaq, Dec 24, 07:48 pm CET
ISIN
US0044682039
Symbol
ACHV

Achieve Life Sciences, Inc. Stock price

$4.46
+0.49 12.34% 1M
+0.65 17.06% 6M
+0.94 26.70% YTD
+0.67 17.68% 1Y
+1.96 78.40% 3Y
-3.52 44.11% 5Y
-2,613.54 99.83% 10Y
-0.57 11.33% 20Y
Nasdaq, Closing price Wed, Dec 24 2025
+0.15 3.48%
ISIN
US0044682039
Symbol
ACHV
Industry

Key metrics

Basic
Market capitalization
$237.4m
Enterprise Value
$199.2m
Net debt
positive
Cash
$48.1m
Shares outstanding
52.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
7.1
Financial Health
Equity Ratio
54.1%
Return on Equity
-190.6%
ROCE
-123.7%
ROIC
-
Debt/Equity
0.3
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-52.1m | -
EBIT
$-52.3m | $-55.6m
Net Income
$-52.4m | $-67.5m
Free Cash Flow
$-40.7m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-67.9% | -
EBIT
-67.4% | -42.3%
Net Income
-58.9% | -69.5%
Free Cash Flow
-63.1%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-1.0
FCF per Share
$-0.8
Short interest
14.0%
Employees
25
Rev per Employee
$0.0
Show more

Is Achieve Life Sciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Achieve Life Sciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Achieve Life Sciences, Inc. forecast:

13x Buy
93%
1x Hold
7%

Analyst Opinions

14 Analysts have issued a Achieve Life Sciences, Inc. forecast:

Buy
93%
Hold
7%

Financial data from Achieve Life Sciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 26 26
90% 90%
-
- Research and Development Expense 26 26
50% 50%
-
-52 -52
68% 68%
-
- Depreciation and Amortization 0.23 0.23
0% 0%
-
EBIT (Operating Income) EBIT -52 -52
67% 67%
-
Net Profit -52 -52
59% 59%
-

In millions USD.

Don't miss a Thing! We will send you all news about Achieve Life Sciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Achieve Life Sciences, Inc. Stock News

Neutral
PRNewsWire
8 days ago
SEATTLE and VANCOUVER, BC , Dec. 17, 2025 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment for nicotine dependence, announced today that the company will be hosting in-person one-on-one meetings coinciding with the 44th Annual J.P. Morgan Healthcare Co...
Neutral
GlobeNewsWire
17 days ago
SEATTLE and VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced that the company has issued inducement grants of stock options to Erik Atkisson, Chief Legal Officer, an...
Neutral
Seeking Alpha
about 2 months ago
Achieve Life Sciences, Inc. ( ACHV ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Nicole Jones Richard A. Stewart - CEO & Executive Director Jaime Xinos - Chief Commercial Officer Mark Oki - Chief Financial Officer Jerry Wan - VP of Finance & Principal Accounting Officer Conference Call Participants Thomas Flaten - Lake Street Capital Markets, LLC, Research Division G...
More Achieve Life Sciences, Inc. News

Company Profile

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

Head office United States
CEO Richard Stewart
Employees 25
Founded 1991
Website achievelifesciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today